Biodexa Pharmaceuticals (NASDAQ:BDRX) Shares to Reverse Split on Friday, October 4th

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares are scheduled to reverse split before the market opens on Friday, October 4th. The 1-25 reverse split was announced on Thursday, September 19th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, October 3rd.

Biodexa Pharmaceuticals Stock Performance

BDRX stock traded down $0.03 during midday trading on Wednesday, reaching $0.28. The company had a trading volume of 998,827 shares, compared to its average volume of 2,405,505. The firm has a 50-day moving average price of $0.52 and a 200-day moving average price of $0.85. Biodexa Pharmaceuticals has a 1 year low of $0.26 and a 1 year high of $8.81. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.26 and a quick ratio of 1.26.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing products aimed at primary and metastatic cancers of the brain in the United Kingdom. The company is developing MTX110, which is currently in Phase I studies for the treatment of diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme.